vimarsana.com
Home
Live Updates
NeuroSense Announces Peer-Reviewed Publication of PrimeC Pha
NeuroSense Announces Peer-Reviewed Publication of PrimeC Pha
NeuroSense Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Erez Eitan ,
Vivian Drory ,
Jeremym Shefner ,
Shiran Zimri ,
Neurosense Head Of Scientific Program ,
Linkedin ,
Twitter ,
Barrow Neurological Institute ,
Drug Administration ,
Neurosense Therapeutics Ltd ,
Clinical Research ,
European Medicines Agency ,
Neuromuscular Diseases Unit ,
Tel Aviv Sourasky Medical Center ,
Principal Investigator ,
Chief Medical Officer ,
Chief Scientific Officer ,
Scientific Program ,
Orphan Drug Designation ,
Massachusetts General Hospital ,
Neuron Derived Exosomes ,
Sense Therapeutics ,
Neurosense Therapeutic ,
Neurosense Therapeutics ,